Qube Research & Technologies (QRT)
BLRX

Qube Research & Technologies (QRT)’s BioLineRX BLRX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-298
Closed -$2.54K – 3497
2024
Q4 		$2.54K Sell
298
-28
-9% -$413 ﹤0.01% 3360
2024
Q3 		$6.99K Hold
326
– – ﹤0.01% 3067
2024
Q2 		$7.38K Sell
326
-20
-6% -$537 ﹤0.01% 2986
2024
Q1 		$15.5K Sell
346
-665
-66% -$33.4K ﹤0.01% 3739
2023
Q4 		$63.5K Buy
1,011
+1,010
+101,000% +$62.5K ﹤0.01% 3245
2023
Q3 		$64 Buy
+1
New +$67 ﹤0.01% 3796

Other funds holding BLRX

Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BLRX Position: Q1 2025 in Review

Qube Research & Technologies (QRT) sold out of BioLineRX (BLRX) in Q1 2025, closing a stake of 298 shares — an estimated $2.54K sold.

Qube Research & Technologies (QRT) first reported a position in BLRX in Q3 2023 and held it in 6 quarters. The position peaked at $63.5K in Q4 2023. 12 funds tracked by Wall St. Rank hold BLRX as of Q1 2025.

  • Qube Research & Technologies (QRT) reported no remaining BioLineRX position as of Q1 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 298 BioLineRX shares in Q1 2025, an estimated $2.54K.
  • Qube Research & Technologies (QRT) first reported a position in BioLineRX in Q3 2023 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s BioLineRX position peaked at $63.5K in Q4 2023.
  • 12 funds tracked by Wall St. Rank held BioLineRX as of Q1 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2025, filed 15 May 2025.